Literature DB >> 14688120

Induction of interleukin-8 in T84 cells by Vibrio cholerae.

Xin Zhou1, Da Q Gao, Jane Michalski, Jorge A Benitez, James B Kaper.   

Abstract

The induction of interleukin-8 (IL-8) in vitro has been suggested to correlate with the reactogenicity of Vibrio cholerae vaccine candidates. V. cholerae vaccine candidate 638, a hemagglutinin protease/hap-defective strain, was recently reported to be well tolerated in human volunteers, suggesting a role for Hap in reactogenicity. We examined the role of hap in the induction of IL-8 in intestinal epithelial T84 cells. Wild-type V. cholerae strains 3038 and C7258 and a vaccine candidate strain, JBK70, induced levels of IL-8 similar to those of their isogenic hap mutants. Supernatant containing Hap did not stimulate IL-8 production at a variety of concentrations tested, suggesting that Hap itself does not induce IL-8 production. Furthermore, supernatant from CVD115, which had deletions of hap and rtxA (encoding repeats in toxin) and was derived from a reactogenic strain, CVD110, induced IL-8 production in T84 cells in a dose-dependent manner. The IL-8-stimulating activity of CVD115 culture supernatants was growth phase dependent and was strongest in stationary phase cultures. This IL-8 stimulator(s) was resistant to heat treatment but sensitive to proteinase. Protease activity in vitro did not correlate with the reactogenicity of V. cholerae vaccine candidates. Our data suggest that Hap is not an IL-8 inducer in T84 cells and that the IL-8 stimulator in the supernatant of V. cholerae culture may play a role in reactogenicity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14688120      PMCID: PMC343975          DOI: 10.1128/IAI.72.1.389-397.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  55 in total

1.  Vibrio cholerae hemagglutinin/protease (HA/protease) causes morphological changes in cultured epithelial cells and perturbs their paracellular barrier function.

Authors:  Z Wu; D Milton; P Nybom; A Sjö; K E Magnusson
Journal:  Microb Pathog       Date:  1996-08       Impact factor: 3.738

Review 2.  Cholera.

Authors:  J B Kaper; J G Morris; M M Levine
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

3.  Randomized, double-blind, placebo-controlled, multicentered trial of the efficacy of a single dose of live oral cholera vaccine CVD 103-HgR in preventing cholera following challenge with Vibrio cholerae O1 El tor inaba three months after vaccination.

Authors:  C O Tacket; M B Cohen; S S Wasserman; G Losonsky; S Livio; K Kotloff; R Edelman; J B Kaper; S J Cryz; R A Giannella; G Schiff; M M Levine
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

4.  Cytotoxic cell vacuolating activity from Vibrio cholerae hemolysin.

Authors:  A Coelho; J R Andrade; A C Vicente; V J Dirita
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

5.  New evidence for an inflammatory component in diarrhea caused by selected new, live attenuated cholera vaccines and by El Tor and Q139 Vibrio cholerae.

Authors:  T M Silva; M A Schleupner; C O Tacket; T S Steiner; J B Kaper; R Edelman; R Guerrant
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

6.  Diverse Pseudomonas aeruginosa gene products stimulate respiratory epithelial cells to produce interleukin-8.

Authors:  E DiMango; H J Zar; R Bryan; A Prince
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

7.  A rapid test for infectious and inflammatory enteritis.

Authors:  J R Miller; L J Barrett; K Kotloff; R L Guerrant
Journal:  Arch Intern Med       Date:  1994 Dec 12-26

8.  Safety, immunogenicity, and efficacy of live attenuated Vibrio cholerae O139 vaccine prototype.

Authors:  T S Coster; K P Killeen; M K Waldor; D T Beattie; D R Spriggs; J R Kenner; A Trofa; J C Sadoff; J J Mekalanos; D N Taylor
Journal:  Lancet       Date:  1995-04-15       Impact factor: 79.321

9.  Initial clinical studies of CVD 112 Vibrio cholerae O139 live oral vaccine: safety and efficacy against experimental challenge.

Authors:  C O Tacket; G Losonsky; J P Nataro; L Comstock; J Michalski; R Edelman; J B Kaper; M M Levine
Journal:  J Infect Dis       Date:  1995-09       Impact factor: 5.226

10.  Peru-15, an improved live attenuated oral vaccine candidate for Vibrio cholerae O1.

Authors:  J R Kenner; T S Coster; D N Taylor; A F Trofa; M Barrera-Oro; T Hyman; J M Adams; D T Beattie; K P Killeen; D R Spriggs
Journal:  J Infect Dis       Date:  1995-10       Impact factor: 5.226

View more
  10 in total

1.  A Vibrio cholerae protease needed for killing of Caenorhabditis elegans has a role in protection from natural predator grazing.

Authors:  Karolis Vaitkevicius; Barbro Lindmark; Gangwei Ou; Tianyan Song; Claudia Toma; Masaaki Iwanaga; Jun Zhu; Agneta Andersson; Marie-Louise Hammarström; Simon Tuck; Sun Nyunt Wai
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-05       Impact factor: 11.205

2.  Enterotoxigenicity of mature 45-kilodalton and processed 35-kilodalton forms of hemagglutinin protease purified from a cholera toxin gene-negative Vibrio cholerae non-O1, non-O139 strain.

Authors:  A Ghosh; D R Saha; K M Hoque; M Asakuna; S Yamasaki; H Koley; S S Das; M K Chakrabarti; A Pal
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

3.  Vibrio cholerae flagellins induce Toll-like receptor 5-mediated interleukin-8 production through mitogen-activated protein kinase and NF-kappaB activation.

Authors:  Lisa M Harrison; Prasad Rallabhandi; Jane Michalski; Xin Zhou; Susan R Steyert; Stefanie N Vogel; James B Kaper
Journal:  Infect Immun       Date:  2008-09-22       Impact factor: 3.441

Review 4.  Pathogenesis of human enterovirulent bacteria: lessons from cultured, fully differentiated human colon cancer cell lines.

Authors:  Vanessa Liévin-Le Moal; Alain L Servin
Journal:  Microbiol Mol Biol Rev       Date:  2013-09       Impact factor: 11.056

Review 5.  Vibrio cholerae hemagglutinin(HA)/protease: An extracellular metalloprotease with multiple pathogenic activities.

Authors:  Jorge A Benitez; Anisia J Silva
Journal:  Toxicon       Date:  2016-03-04       Impact factor: 3.033

6.  Cytotoxic and Inflammatory Responses Induced by Outer Membrane Vesicle-Associated Biologically Active Proteases from Vibrio cholerae.

Authors:  Ayan Mondal; Rima Tapader; Nabendu Sekhar Chatterjee; Amit Ghosh; Ritam Sinha; Hemanta Koley; Dhira Rani Saha; Manoj K Chakrabarti; Sun Nyunt Wai; Amit Pal
Journal:  Infect Immun       Date:  2016-04-22       Impact factor: 3.441

7.  Alpha versus beta: are we on the way to resolve the mystery as to which is the endogenous ligand for natural killer T cells?

Authors:  Y Ilan
Journal:  Clin Exp Immunol       Date:  2009-09-30       Impact factor: 4.330

8.  Studies on a novel serine protease of a ΔhapAΔprtV Vibrio cholerae O1 strain and its role in hemorrhagic response in the rabbit ileal loop model.

Authors:  Aurelia Syngkon; Sridhar Elluri; Hemanta Koley; Pramod K Rompikuntal; Dhira Rani Saha; Manoj K Chakrabarti; Rupak K Bhadra; Sun Nyunt Wai; Amit Pal
Journal:  PLoS One       Date:  2010-09-30       Impact factor: 3.240

9.  The Vibrio cholerae MARTX toxin silences the inflammatory response to cytoskeletal damage before inducing actin cytoskeleton collapse.

Authors:  Patrick J Woida; Karla J F Satchell
Journal:  Sci Signal       Date:  2020-01-14       Impact factor: 9.517

10.  Vibrio cholerae cytolysin causes an inflammatory response in human intestinal epithelial cells that is modulated by the PrtV protease.

Authors:  Gangwei Ou; Pramod Kumar Rompikuntal; Aziz Bitar; Barbro Lindmark; Karolis Vaitkevicius; Sun Nyunt Wai; Marie-Louise Hammarström
Journal:  PLoS One       Date:  2009-11-12       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.